In California, faceoff between major insurer and health system shows hazards of consolidation

For weeks, more than half a million Anthem Blue Cross enrollees who receive health care from the University of California were held in suspense.

LVAD Monitoring App Recall; ADHD Drug & CVD Risk; Value of ATTR Treatments?

The FDA announced the class I recall of an Abbott app used to monitor patients using the HeartMate 3 Left Ventricular Assist Device (LVAD), as

March 13, 2024

FDA seeks feedback on expansion of premarket cybersecurity guidance

Dive Brief: The Food and Drug Administration has requested feedback on plans to add a new section to the premarket cybersecurity guidance finalized last year. Through

March 13, 2024

Ivan Cheung’s post-Eisai life takes hold at NextPoint Therapeutics; Sanofi, Takeda announce CFO exits

Ivan Cheung, who led Eisai’s US business and was a central figure in the biotech’s Alzheimer’s work, has stepped into the CEO position at a

February 3, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.